Jim Cramer on the Viacom-CBS Merger: Enough Is Enough

Jim Cramer on the Viacom-CBS Merger: Enough Is Enough

Here's what has Jim Cramer fed up with the much-awaited merger between Viacom and CBS.

Viacom Creates 2 Interesting Chart Patterns to Keep Traders on Edge

Viacom Creates 2 Interesting Chart Patterns to Keep Traders on Edge

The technical signs do not instill a ton of confidence, though a bit of strength could change the outlook.

Viacom Stock Pops as Media Merger with CBS Set to Close

Viacom Stock Pops as Media Merger with CBS Set to Close

Viacom shareholders may finally be rewarded this week for their patience.

Why Wall Street Is Still Riding With Uber

Why Wall Street Is Still Riding With Uber

Uber's crash on earnings does not mean the stock is totaled according to analysts covering the stock.

Canopy Growth to Buy Beckley Canopy Therapeutics

Canopy Growth to Buy Beckley Canopy Therapeutics

Canopy Growth agrees to buy Beckley Canopy Therapeutics, a joint venture it initially launched in 2018 to research and develop cannabis-based medicines.

Broadcom Buys Symantec's Enterprise Business for $10.7 Billion

Broadcom Buys Symantec's Enterprise Business for $10.7 Billion

The news came just ahead of Symantec's earnings release, which saw the company beat earnings and revenue expectations for the second quarter.

CBS and AT&T Strike Deal, Ending 20-Day Blackout

CBS and AT&T Strike Deal, Ending 20-Day Blackout

CBS and AT&T announce a truce for a new multi-year content carriage agreement, ending a 20-day-long blackout that began when the previous, seven-year deal expired.

Vitamin Shoppe Soars on Deal to Be Acquired by Liberty Tax

Vitamin Shoppe Soars on Deal to Be Acquired by Liberty Tax

Shares of nutritional products and supplements retailer Vitamin Shoppe surge after announcing it is being acquired by Liberty Tax in an all-cash deal valued at about $208 million.

Cambrex Soars on Buyout Deal With Private-Equity Firm Permira

Cambrex Soars on Buyout Deal With Private-Equity Firm Permira

Shares of life-sciences company Cambrex surge after the company strikes a deal to be acquired by pharmaceutical-focused private-equity firm Permira funds for $2.4 billion, including debt.

TheStreet's Shareholders Approve Sale to TheMaven; Deal to Close Wednesday

TheStreet's Shareholders Approve Sale to TheMaven; Deal to Close Wednesday

Digital-media company TheMaven to acquire all outstanding shares of TheStreet for $16.5 million cash plus a $3.35-a-share special dividend. Investors holding more than 96% of shares OK'd the deal.